Income Taxes
Income taxes are accounted for under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences are expected to become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment.
The Company includes interest accrued on the underpayment of income taxes and certain interest expense and penalties, if any, related to unrecognized tax benefits as a component of the income tax provision. The Company recorded a valuation allowance against its U.S., e-bot7 Germany, and Bulgaria deferred tax assets as it considered its cumulative losses in recent years as a significant piece of negative evidence. Since valuation allowances are evaluated by jurisdiction, the Company believes that the deferred tax assets related to LivePerson Australia Pty. Ltd., Engage Pty. Ltd., LivePerson (UK) Ltd., LivePerson Japan, and LivePerson Ltd. (Israel) are more likely than not to be realized as these jurisdictions have positive cumulative pre-tax book income after adjusting for permanent and one-time items.
The One Big Beautiful Bill Act (“OBBBA”) was signed into law on July 4, 2025, and makes changes to the deductibility of certain business expenditures including interest expense, research and development expenditures, and property and equipment, and makes changes to elements of U.S. cross-border taxation. The Company implemented the changes enacted under OBBBA.
OBBBA impacted the Company’s deferred tax assets as of July 4, 2025, the date of enactment, via the reversal of $32.0 million of deferred tax assets resulting from capitalized research expenses incurred through December 31, 2024. The reversal is reflected on the Company’s annual financial statements as of and for the year ended December 31, 2025.
The Company had a valuation allowance on certain deferred tax assets for the years ended December 31, 2025, 2024, and 2023 of $243.2 million, $234.6 million, and $211.2 million, respectively. For the years ended December 31, 2025 and 2024, increases in the valuation allowance of $8.6 million and $23.4 million, respectively, were recorded as an expense.
As of December 31, 2025, the Company had $646.0 million of federal NOL carryforwards available to offset future taxable income. Included in this amount is $49.4 million of federal NOL carryovers from the Company’s acquisition of Tenfold in 2021 and $64.9 million of federal NOL carryovers from the Company’s acquisition of VoiceBase in 2021. Of these federal NOL carryforwards, $67.7 million were generated in taxable years ending on or before December 31, 2017 and will expire in various years through 2037. Federal NOL carryforwards generated in taxable years ending after December 31, 2017, do not expire, but generally may only offset up to 80% of federal taxable income earned in a taxable year.
Section 382 of the Internal Revenue Code (“IRC Section 382”) limits a corporation’s ability to utilize NOL and tax credit carryforwards following an ownership change, as defined under IRC Section 382. The Company experienced an ownership change effective September 12, 2025. As a result, utilization of the Company’s federal NOL carryforwards is subject to an annual limitation of approximately $3.3 million.
On January 22, 2024, the Company entered into a Tax Benefits Preservation Plan designed to reduce the risk of substantial impairment to its NOLs that could result from an “ownership change” within the meaning of Section 382 of the Code. The Tax Benefits Preservation Plan creates a disincentive for any person or group of affiliated or associated persons to acquire 4.9% or more of the Company’s outstanding common stock (any such person or group, an “Acquiring Person”), or to further accumulate shares of the Company’s outstanding common stock if such person or group of person already owns 4.9% or more of the Company’s outstanding common stock, without the approval of the Company’s Board, unless and until the Board determines that the Tax Benefits Preservation Plan is no longer necessary or desirable for preservation of the Company’s NOLs.
In connection therewith, on January 22, 2024, the Board authorized a dividend of one right (a “Right”) for each outstanding share of common stock of the Company. Each Right entitles the registered holder to purchase from the Company one one-thousandth of a share of Series A Junior Participating Preferred Stock, par value $0.001 per share, at a price of $18.00, subject to certain adjustments. The Rights will separate from the common stock and become exercisable and separately transferable at the close of business on the date that is the tenth (10th) business day after the earlier of (i) the date on which on which a press release is issued or other public announcement is made indicating that a person or group of affiliated or associated persons has become an Acquiring Person and (ii) the date on which a tender offer or exchange offer is commenced that, upon consummation, would result in a person or group of affiliated or associated persons becoming an Acquiring Person. If issued and not redeemed by the Company, each holder of a Right (other than the Acquiring Person, the Rights of which shall become null and void) will, upon exercise, be entitled to purchase shares of the Company’s common stock having a then-current market value equal to two times the exercise price of the Right. However, prior to exercise, a Right does not give its holder any rights as a stockholder of the Company, including, without limitation, the right to vote or to receive dividends.
The domestic and foreign components of loss before provision for income taxes consist of the following:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| | | | | |
| (In thousands) |
| United States | $ | (59,467) | | | $ | (125,764) | | | $ | (95,773) | |
| Israel | 375 | | | (42) | | | 1,074 | |
| United Kingdom | 1,099 | | | 1,681 | | | 1,481 | |
| Netherlands | 641 | | | 725 | | | 2,030 | |
| Australia | 446 | | | 662 | | | (412) | |
| Germany | (8,282) | | | (10,246) | | | (5,453) | |
Other (1) | 1,407 | | | 1,446 | | | 781 | |
| Total | $ | (63,781) | | | $ | (131,538) | | | $ | (96,272) | |
——————————————
(1)Includes Bulgaria, Canada, France, India, Italy, Japan, , Mexico, Poland, Singapore and Spain.
No additional provision has been made for U.S. income taxes on the undistributed earnings of its wholly-owned Israeli subsidiary, LivePerson Ltd., as such earnings have been taxed in the U.S. A provision for the undistributed earnings of the Company’s other foreign subsidiaries has not been provided because the Company intends to indefinitely reinvest such earnings outside of the U.S., though if these foreign earnings were to be repatriated in the future the related U.S. tax liability would be immaterial through December 31, 2025.
The provision for income taxes consists of the following:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| | | | | |
| (In thousands) |
| Current income taxes: | | | | | |
| U.S. Federal | $ | — | | | $ | — | | | $ | — | |
| State and local | 998 | | | 366 | | | 239 | |
| Foreign | 1,832 | | | 1,746 | | | 2,878 | |
| Total current income taxes | 2,830 | | | 2,112 | | | 3,117 | |
| | | | | |
| Deferred income taxes: | | | | | |
| U.S. Federal | 166 | | | 72 | | | 651 | |
| State and local | 491 | | | 532 | | | 488 | |
| Foreign | (35) | | | 19 | | | (93) | |
| Total deferred income taxes | 622 | | | 623 | | | 1,046 | |
| Total provision for income taxes | $ | 3,452 | | | $ | 2,735 | | | $ | 4,163 | |
As further described in Note 1 - Description of Business and Summary of Significant Accounting Policies, the Company has elected to prospectively adopt the guidance in ASU 2023-09. The following table is a reconciliation of the U.S. federal statutory rate of 21% to the Company’s effective rate for the year ended December 31, 2025 in accordance with the guidance in ASU 2023-09:
| | | | | | | | | | | |
| Year ended December 31, 2025 |
| Amount | | Percent |
| | | |
| (In thousands) | | |
| Loss before provision for income taxes | $ | (63,781) | | | |
| | | |
| Income tax benefit at U.S. federal statutory rate | (13,394) | | | 21.00 | % |
State and local income taxes (net of federal income tax effect) (1) | 1,702 | | | (2.67) | % |
| Foreign tax effects: | | | |
| | | |
| | | |
| | | |
| Germany | | | |
| Goodwill impairment | 2,513 | | | (3.94) | % |
| Rate differential | (993) | | | 1.56 | % |
| Other | 218 | | | (0.34) | % |
| Other foreign countries | 282 | | | (0.44) | % |
| Effect of cross-border taxes laws | 79 | | | (0.12) | % |
| Changes in valuation allowances | 5,905 | | | (9.26) | % |
| | | |
| Nontaxable or nondeductible items: | | | |
| Goodwill impairment | 7,053 | | | (11.06) | % |
| Stock-based compensation - excess tax benefit / (tax deficiency) | 1,856 | | | (2.91) | % |
| Warrant revaluation | (3,045) | | | 4.77 | % |
| | | |
| | | |
| | | |
| Other nontaxable or nondeductible items | 681 | | | (1.07) | % |
| | | |
| Change in unrecognized tax benefits: | 683 | | | (1.07) | % |
| Other adjustments | | | |
| Other items | (88) | | | 0.14 | % |
| Total income tax expense and effective rate | $ | 3,452 | | | (5.41) | % |
(1) State taxes in California make up the majority (greater than 50%) of the tax effect in this category in 2025.
The difference between the total income taxes computed at the federal statutory rate and the provision for income taxes consists of the following:
| | | | | | | | | | | | | | | |
| | December 31, |
| | | 2024 | | 2023 |
| Federal statutory rate | | | 21.00 | % | | 21.00 | % |
| State taxes, net of federal benefit | | | 3.16 | % | | 3.94 | % |
| Non-deductible expenses – stock-based compensation | | | (0.14) | % | | (0.55) | % |
| | | | | |
| Non-deductible expenses – earn-out | | | — | % | | 5.50 | % |
| Non-deductible excess compensation | | | (0.14) | % | | (0.04) | % |
| Foreign taxes | | | (0.53) | % | | (0.94) | % |
| Valuation allowance | | | (18.19) | % | | (24.40) | % |
| Stock based compensation – excess tax benefit / (tax deficiency) | | | (5.00) | % | | (7.00) | % |
| Goodwill impairment | | | (7.96) | % | | (2.59) | % |
| Sale of subsidiary | | | 7.18 | % | | 1.69 | % |
| Debt restructuring | | | (1.83) | % | | — | % |
| Other | | | 0.37 | % | | (0.93) | % |
| Total provision | | | (2.08) | % | | (4.32) | % |
The amounts of income tax related taxes paid, net of refunds received, were as follows:
| | | | | |
| Year ended December 31, 2025 |
| (In thousands) |
| State | $ | 55 | |
| |
| Foreign: | |
| United Kingdom | 490 | |
| Germany | 438 | |
| India | 309 | |
| Poland | 240 | |
| Israel | 176 | |
| Netherlands | (637) | |
| All other | 95 | |
| Total foreign | 1,111 | |
| Income taxes, net of amounts refunded | 1,166 | |
| Other taxes | 41 | |
| Total taxes paid, net of refunds | $ | 1,207 | |
The effects of temporary differences and federal NOL carryforwards that give rise to significant portions of federal deferred tax assets and deferred tax liabilities as of the dates presented:
| | | | | | | | | | | |
| December 31, |
| 2025 | | 2024 |
| | | |
| (In thousands) |
| Deferred tax assets, net: | | | |
| Net operating loss carryforwards | $ | 173,899 | | | $ | 172,923 | |
| | | |
| R&D tax credit | 1,757 | | | 1,757 | |
| Original issue discount | 25,502 | | | 7,330 | |
| Interest | 13,811 | | | 7,544 | |
| Operating lease liabilities | (12) | | | (1) | |
| Accounts payable and accrued expenses | 4,622 | | | 4,266 | |
| Non-cash compensation | 6,952 | | | 7,617 | |
| Intangibles amortization | 2,978 | | | 3,170 | |
| R&D capitalization | 32,732 | | | 58,237 | |
| Allowance for credit loss | 843 | | | 2,067 | |
| Total deferred tax assets | 263,084 | | | 264,910 | |
| Less valuation allowance | (243,240) | | | (234,620) | |
| Deferred tax assets, net | 19,844 | | | 30,290 | |
| Deferred tax liabilities: | | | |
| Property and equipment | (9,929) | | | (12,337) | |
| | | |
| Goodwill amortization and contingent earn-out adjustments | (9,607) | | | (9,048) | |
| Outside basis difference in subsidiary stock | — | | | (8,040) | |
| Operating lease right-of-use assets | 7 | | | 4 | |
| Total deferred tax liabilities | (19,529) | | | (29,421) | |
| Net deferred tax assets | $ | 315 | | | $ | 869 | |
The Company has U.S. federal, Australian, and German NOLs of $646.0 million, $0.2 million, and $30.8 million, respectively. The Australian and German NOLs can be carried forward indefinitely. For the federal NOLs, $578.3 million can be
carried forward indefinitely, $67.7 million will expire between 2030 and 2037. The Company has $522.9 million of state NOLs, of which $133.6 million can be carried forward indefinitely and $389.2 million will expire between 2026 and 2045.
ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in the financial statements in accordance with other provisions contained within this guidance. This topic prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by the taxing authorities. The amount recognized is measured as the largest amount of benefit that is greater than 50% likely of being realized upon ultimate audit settlement. The Company had unrecognized tax benefits of $3.8 million and $3.5 million as of December 31, 2025 and 2024, respectively, that would affect the effective tax rate if recognized. Accrued interest and penalties included in the Company’s liability related to unrecognized tax benefits and recorded in Accrued expenses and other current liabilities was $1.2 million and $0.7 million as of December 31, 2025 and 2024, respectively. There are no unrecognized tax benefits expected to reverse in the next twelve months and impact the effective tax rate.
A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2025 | | 2024 | | 2023 |
| | | | | |
| (In thousands) |
| Unrecognized tax benefits balance, beginning of year | $ | 3,536 | | | $ | 3,061 | | | $ | 2,721 | |
| | | | | |
| Gross increase for tax positions of prior years | — | | | 204 | | | — | |
| Gross increase for tax positions of current year | 286 | | | 271 | | | 340 | |
| | | | | |
| | | | | |
| | | | | |
| Unrecognized tax benefits, end of year | $ | 3,822 | | | $ | 3,536 | | | $ | 3,061 | |
The tax years subject to examination by major tax jurisdictions include the years 2020 and forward for U.S. states and cities, the years 2021 and forward for U.S. Federal, and the years 2019 and forward for certain foreign jurisdictions.